Compound Detail
CHEMBL4064585
Enter ChEMBL ID:
Free Research Context
This compound will appear in recent viewed items on the research home for this browser.
Research home
View demo workspace
Basic Information
| ChEMBL ID | CHEMBL4064585 |
| Phase | Preclinical |
| Structure Type | MOL |
| InChI Key | QWQDULIQJQIEKB-UHFFFAOYSA-N |
3
Targets
4
Activities
1
Assay Types
0
PK Parameters
3
Publications
0
Known Names
Molecular Properties
443.5
MW (Da)
2.62
ALogP
8
HBA
3
HBD
112.6
PSA (Ų)
0.37
QED
0
Ro5 Violations
12
Rot. Bonds
Drug Information
| Molecule Type | Small molecule |
| Availability | Unknown |
| Chirality | Unknown |
Activity Summary
IC50 4 meas. best 5.9
Target Activity Profile
Activity Data Samples
Top measurements by pChEMBL value
| Target | Type | Rel. | Value | Units | pChEMBL | Assay | PubMed |
|---|---|---|---|---|---|---|---|
| A549 | IC50 | = | 1260.0 | nM | 5.9 | Cytotoxicity against human A549 cells assessed as reduction in cell viability af... | 28117202 |
| HepG2 | IC50 | = | 2640.0 | nM | 5.58 | Cytotoxicity against human HepG2 cells assessed as reduction in cell viability a... | 28117202 |
| HepG2 | IC50 | = | 2630.27 | nM | 5.58 | Cytotoxicity against human HepG2 cells assessed as reduction in cell viability a... | 28117202 |
| Unchecked | IC50 | = | 5890.0 | nM | 5.23 | Cytotoxicity against human BCG823 cells assessed as reduction in cell viability ... | 28117202 |
Literature References
| PubMed | DOI | Target Context | # Activities |
|---|---|---|---|
| 28117202 | 10.1016/j.bmcl.2016.12.076 | HepG2 | 2 |
| 28117202 | 10.1016/j.bmcl.2016.12.076 | A549 | 1 |
| 28117202 | 10.1016/j.bmcl.2016.12.076 | Unchecked | 1 |
Data from ChEMBL 36 via Core Engine